MedTrace Logo

Memorisation of Phonologic Information Among Children With Oral Language Developement Disorder

NCT02609542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2025-12-04

No results posted yet for this study

Summary

The disorder of oral language development is defined by the delay in language acquisition in children who possess efficient auditory acuity and normal non verbal intellect.

The diversity of language developement disorders depends either in the expressive level or in the receptive level leading to divers syndromes and symptoms. These syndromes and symptoms are regrouped under the name of STOL (Specific Troubles of Oral Language).

In the current project the visual exploitation and learning capability of children presenting a STOL condition will be compared to patients with a normal development. The investigator's hypothesis is as follows: STOL patients for whom the STOL disorder is reduced between 4 and 7 years of age will present a better performance at verbal memorisation, compared to patients with a persistent STOL condition after the age of 6.

Conditions

  • Language Development Disorders

Interventions

OTHER

Eye Tracking

Eye tracker will allows the recording of various information concerning eye fixation (number, duration, location) and saccadic eye movement (speed, range, number, duration) in order to determine the interplay between linguistic and visual information processing during tests performance

Sponsors & Collaborators

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Delphine Fleurion, Psychologist · Groupement des Hôpitaux de l'Institut Catholique de Lille

Eligibility

Min Age
45 Months
Max Age
95 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02609542 on ClinicalTrials.gov